|
| Status |
Public on Oct 16, 2023 |
| Title |
MZ1, a BRD4 inhibitor, exerted its anti-cancer effects by targeting the super-enhancer-regulated gene SDC1 in Glioblastoma |
| Organism |
Homo sapiens |
| Experiment type |
Genome binding/occupancy profiling by high throughput sequencing
Expression profiling by high throughput sequencing
|
| Summary |
This SuperSeries is composed of the SubSeries listed below.
|
| |
|
| Overall design |
Refer to individual Series
|
| |
|
| Citation(s) |
38365636 |
| Submission date |
Oct 08, 2023 |
| Last update date |
Feb 26, 2024 |
| Contact name |
Gen Li |
| E-mail(s) |
ligen925@yeah.net
|
| Organization name |
Children's Hospital of Soochow University
|
| Street address |
No. 92 Zhongnan Street
|
| City |
Suzhou |
| State/province |
Jiangsu |
| ZIP/Postal code |
215025 |
| Country |
China |
| |
|
| Platforms (2) |
| GPL24676 |
Illumina NovaSeq 6000 (Homo sapiens) |
| GPL28038 |
DNBSEQ-G400 (Homo sapiens) |
|
| Samples (7)
|
|
| This SuperSeries is composed of the following SubSeries: |
| GSE244878 |
MZ1, a BRD4 inhibitor, exerted its anti-cancer effects by targeting the super-enhancer-regulated gene SDC1 in Glioblastoma [RNA-Seq] |
| GSE244893 |
MZ1, a BRD4 inhibitor, exerted its anti-cancer effects by targeting the super-enhancer-regulated gene SDC1 in Glioblastoma [ChIP-Seq] |
|
| Relations |
| BioProject |
PRJNA1025846 |
Less...
More...